Related Experiment Video
Updated: Jun 3, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Medicaid Tobacco And Nicotine Cessation Treatment Rates Remained Low, 2019-24
Lisa Clemans-Cope1, Maya Payton2, Victoria Lynch3
1Lisa Clemans-Cope (lclemans@urban.org), Urban Institute, Washington, D.C.
Abstract:
Tobacco use drives large health and fiscal costs for Medicaid, yet few enrollees who use these products receive cessation pharmacotherapy. We estimated that 10.4 percent of daily tobacco or nicotine users received cessation medications in 2024, and Medicaid programs spent $137.6 million on such treatments that year. State-level treatment rates ranged from 1.3 percent to 26.6 percent.
More Related Videos
14:21Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
08:47Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drug Dependence
CNS Depressants: Alcohol and Nicotine
Longitudinal Research
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...